marketcap
Facebook
Twitter
Telegram
Fehler meldenQuartalsbericht 2024-Q3
hinzugefügt 13.11.2024
X4 Pharmaceuticals Finanzdaten 2011-2024 | XFOR
Jahresabschluß X4 Pharmaceuticals
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Marktkapitalisierung |
233 M | 55.3 M | 53 M | 157 M | 99.2 M | 40.1 M | 27 M | - | - | - | - | - | - |
Anteile |
178 M | 63.5 M | 25.7 M | 20.1 M | 11.5 M | 2.38 M | 344 K | - | - | - | - | - | - |
Kurshistorie |
1.31 | 0.87 | 2.06 | 7.81 | 8.3 | 16.4 | 75.7 | - | - | - | - | - | - |
Nettogewinn |
-101 M | -93.9 M | -88.7 M | -62.1 M | -52.8 M | -43 M | -33.9 M | -23 M | -13.2 M | - | - | - | - |
Umsatz |
- | - | - | 3 M | - | 3.5 M | - | - | - | - | - | - | - |
Umsatzkosten |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-108 M | -87.6 M | -85.1 M | -59.9 M | -51.7 M | -29.1 M | -22.2 M | -24.3 M | - | - | - | - | - |
Zinsaufwendungen |
5.78 M | 3.99 M | 3.64 M | 2.69 M | 2.15 M | 720 K | 490 K | 2.52 M | - | - | - | - | - |
EBITDA |
-107 M | -87.1 M | -84.6 M | -59.5 M | -47.7 M | -42.6 M | -31.9 M | -21.6 M | -12.4 M | - | - | - | - |
Betriebsaufwand |
108 M | 87.6 M | 85.1 M | 62.9 M | 47.8 M | 46.2 M | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
35.5 M | 27 M | 24.7 M | 20.9 M | 17.6 M | 18.4 M | 8 M | 6.52 M | 2.12 M | - | - | - | - |
Alle Zahlen in USD-Währung
Gewinn / Verlust Vierteljährlich X4 Pharmaceuticals
| 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Anteile |
201 M | 200 M | 200 M | 167 M | 197 M | 169 M | 146 M | 122 M | 83.2 M | 35.4 M | 33.7 M | 28.1 M | 26.6 M | 26.5 M | 20.8 M | 16.3 M | 20.1 M | 20 M | 20 M | 16.1 M | 14.6 M | 13.2 M | 1.72 M | 352 K | 459 K | 459 K | 458 K | 14.3 M | 514 K | 514 K | 514 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Nettogewinn |
-36.7 M | 90.8 M | -51.8 M | - | -2.3 M | -55.7 M | -24 M | - | -21.6 M | -21.2 M | -22 M | - | -20.2 M | -19.6 M | -18.7 M | - | -17.4 M | -15.1 M | -11.1 M | - | -17.7 M | -13.4 M | -10.9 M | -9.36 M | -8.6 M | -6.03 M | -7.37 M | -11.2 M | -11.6 M | -5.7 M | -5.38 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatz |
560 K | 563 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 3 M | - | - | - | - | 3.5 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Umsatzkosten |
227 K | 268 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Bruttoertrag |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsergebnis |
-34.5 M | 71.1 M | -37.3 M | - | -27.2 M | -25.8 M | -29.3 M | - | -20.2 M | -20.6 M | -21.3 M | - | -19.1 M | -19 M | -17.9 M | - | -17 M | -14.7 M | -10.6 M | - | -17 M | -13.4 M | -10.4 M | - | -8.54 M | -6.38 M | -6.11 M | - | -13.1 M | -5.64 M | -5.83 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zinsaufwendungen |
2.41 M | 2.18 M | 1.87 M | - | 1.63 M | 1.15 M | 1.11 M | - | 1.02 M | 918 K | 913 K | - | 920 K | 905 K | 891 K | - | 697 K | 687 K | 584 K | - | 688 K | 512 K | 399 K | - | 148 K | 167 K | 169 K | - | 343 K | 444 K | 1.02 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
EBITDA |
-34.3 M | 71.2 M | -37.2 M | - | - | - | -29.2 M | - | -19.8 M | -20.6 M | -21.1 M | - | -18.8 M | -19 M | -17.8 M | - | -16.7 M | -14.6 M | -10.5 M | - | -16.9 M | -13.4 M | -10.4 M | - | -8.47 M | -6.32 M | -6.08 M | - | -12.9 M | -5.55 M | -5.78 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Betriebsaufwand |
- | - | 37.3 M | - | 27.2 M | 25.8 M | 29.3 M | - | 20.2 M | 20.6 M | 21.3 M | - | 19.1 M | 19 M | 17.9 M | - | 17 M | 14.7 M | 13.6 M | - | 17 M | 13.4 M | 10.4 M | 13 M | 8.54 M | 6.38 M | 6.11 M | 11.6 M | 13.1 M | 5.64 M | 5.83 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Allgemeine und Verwaltungsausgaben |
15.7 M | 13.3 M | 17.4 M | - | 8.13 M | 10.2 M | 7.24 M | - | 6.04 M | 6.75 M | 7.66 M | - | 5.93 M | 5.8 M | 5.83 M | - | 5.6 M | 5.32 M | 4.67 M | - | 4.38 M | 4.56 M | 4.78 M | - | 2.39 M | 1.62 M | 1.37 M | - | 2.46 M | 1.74 M | 1.44 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung